202 related articles for article (PubMed ID: 33410159)
1. Pilot-scale demonstration of an end-to-end integrated and continuous biomanufacturing process.
Coolbaugh MJ; Varner CT; Vetter TA; Davenport EK; Bouchard B; Fiadeiro M; Tugcu N; Walther J; Patil R; Brower K
Biotechnol Bioeng; 2021 Sep; 118(9):3287-3301. PubMed ID: 33410159
[TBL] [Abstract][Full Text] [Related]
2. Integrated continuous production of recombinant therapeutic proteins.
Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
[TBL] [Abstract][Full Text] [Related]
3. Model-based design and control of a small-scale integrated continuous end-to-end mAb platform.
Gomis-Fons J; Schwarz H; Zhang L; Andersson N; Nilsson B; Castan A; Solbrand A; Stevenson J; Chotteau V
Biotechnol Prog; 2020 Jul; 36(4):e2995. PubMed ID: 32233078
[TBL] [Abstract][Full Text] [Related]
4. Design and operation of a continuous integrated monoclonal antibody production process.
Steinebach F; Ulmer N; Wolf M; Decker L; Schneider V; Wälchli R; Karst D; Souquet J; Morbidelli M
Biotechnol Prog; 2017 Sep; 33(5):1303-1313. PubMed ID: 28691347
[TBL] [Abstract][Full Text] [Related]
5. Improving an intensified and integrated continuous bioprocess platform for biologics manufacturing.
Zhou H; Fang M; Zheng X; Zhou W
Biotechnol Bioeng; 2021 Sep; 118(9):3618-3623. PubMed ID: 33788278
[TBL] [Abstract][Full Text] [Related]
6. Integrated continuous biomanufacturing on pilot scale for acid-sensitive monoclonal antibodies.
Schwarz H; Gomis-Fons J; Isaksson M; Scheffel J; Andersson N; Andersson A; Castan A; Solbrand A; Hober S; Nilsson B; Chotteau V
Biotechnol Bioeng; 2022 Aug; 119(8):2152-2166. PubMed ID: 35470430
[TBL] [Abstract][Full Text] [Related]
7. Process design of a fully integrated continuous biopharmaceutical process using economic and ecological impact assessment.
Ding C; Ardeshna H; Gillespie C; Ierapetritou M
Biotechnol Bioeng; 2022 Dec; 119(12):3567-3583. PubMed ID: 36109341
[TBL] [Abstract][Full Text] [Related]
8. Implementation of Fully Integrated Continuous Antibody Processing: Effects on Productivity and COGm.
Arnold L; Lee K; Rucker-Pezzini J; Lee JH
Biotechnol J; 2019 Feb; 14(2):e1800061. PubMed ID: 29729129
[TBL] [Abstract][Full Text] [Related]
9. Single pass diafiltration integrated into a fully continuous mAb purification process.
Rucker-Pezzini J; Arnold L; Hill-Byrne K; Sharp T; Avazhanskiy M; Forespring C
Biotechnol Bioeng; 2018 Aug; 115(8):1949-1957. PubMed ID: 29663323
[TBL] [Abstract][Full Text] [Related]
10. The design basis for the integrated and continuous biomanufacturing framework.
Coffman J; Bibbo K; Brower M; Forbes R; Guros N; Horowski B; Lu R; Mahajan R; Patil U; Rose S; Shultz J
Biotechnol Bioeng; 2021 Sep; 118(9):3323-3333. PubMed ID: 33522595
[TBL] [Abstract][Full Text] [Related]
11. Integrated continuous biomanufacturing platform with ATF perfusion and one column chromatography operation for optimum resin utilization and productivity.
Kamga MH; Cattaneo M; Yoon S
Prep Biochem Biotechnol; 2018 May; 48(5):383-390. PubMed ID: 29509101
[TBL] [Abstract][Full Text] [Related]
12. Impact of media and antifoam selection on monoclonal antibody production and quality using a high throughput micro-bioreactor system.
Velugula-Yellela SR; Williams A; Trunfio N; Hsu CJ; Chavez B; Yoon S; Agarabi C
Biotechnol Prog; 2018 Jan; 34(1):262-270. PubMed ID: 29086492
[TBL] [Abstract][Full Text] [Related]
13. A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies.
Xenopoulos A
J Biotechnol; 2015 Nov; 213():42-53. PubMed ID: 25959171
[TBL] [Abstract][Full Text] [Related]
14. Scale-down model qualification of ambr® 250 high-throughput mini-bioreactor system for two commercial-scale mAb processes.
Manahan M; Nelson M; Cacciatore JJ; Weng J; Xu S; Pollard J
Biotechnol Prog; 2019 Nov; 35(6):e2870. PubMed ID: 31207168
[TBL] [Abstract][Full Text] [Related]
15. Large-scale monoclonal antibody purification by continuous chromatography, from process design to scale-up.
Girard V; Hilbold NJ; Ng CK; Pegon L; Chahim W; Rousset F; Monchois V
J Biotechnol; 2015 Nov; 213():65-73. PubMed ID: 25962790
[TBL] [Abstract][Full Text] [Related]
16. Online monitoring and control of upstream cell culture process using 1D and 2D-LC with SegFlow interface.
Chemmalil L; Wasalathanthri DP; Zhang X; Kuang J; Shao C; Barbour R; Bhavsar S; Prabhakar T; Knihtila R; West J; Puri N; McHugh K; Rehmann MS; He Q; Xu J; Borys MC; Ding J; Li Z
Biotechnol Bioeng; 2021 Sep; 118(9):3593-3603. PubMed ID: 34185315
[TBL] [Abstract][Full Text] [Related]
17. Process-wide control and automation of an integrated continuous manufacturing platform for antibodies.
Feidl F; Vogg S; Wolf M; Podobnik M; Ruggeri C; Ulmer N; Wälchli R; Souquet J; Broly H; Butté A; Morbidelli M
Biotechnol Bioeng; 2020 May; 117(5):1367-1380. PubMed ID: 32022243
[TBL] [Abstract][Full Text] [Related]
18. Continuous and Integrated Expression and Purification of Recombinant Antibodies.
Vogg S; Wolf MKF; Morbidelli M
Methods Mol Biol; 2018; 1850():147-178. PubMed ID: 30242686
[TBL] [Abstract][Full Text] [Related]
19. Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study.
Xu J; Xu X; Huang C; Angelo J; Oliveira CL; Xu M; Xu X; Temel D; Ding J; Ghose S; Borys MC; Li ZJ
MAbs; 2020 Jan; 12(1):1770669. PubMed ID: 32425110
[TBL] [Abstract][Full Text] [Related]
20. Determination of protein concentration in downstream biomanufacturing processes by in-line index of refraction.
Harris SA; Patel BA; Gospodarek A; Desai J; de Janon Gutiérrez A; Botonjic-Sehic E; Brower M; Pinto NDS
Biotechnol Prog; 2021 Sep; 37(5):e3187. PubMed ID: 34164947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
